Designing personalised cancer treatments

Journal of Controlled Release

Volumn 172, Issue 2, 2013, Pages 405-409

  Cree, Ian A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

ATP; Cancer; Cell; Culture; Genotyping; RT PCR

Indexed keywords

CANCER; CLINICAL EFFICACY; CLINICAL PRACTICES; GENOTYPING; MOLECULAR UNDERSTANDING; PERSONALISED MEDICINES; PRIMARY CELL CULTURES; RT-PCR;

ADENOSINETRIPHOSPHATE; CELL CULTURE; CELLS; DESIGN; TUMORS;

DISEASES;

ANTINEOPLASTIC AGENT; CRIZOTINIB; DACARBAZINE; GEMCITABINE; TREOSULFAN; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER THERAPY; CELL MEDIATED CYTOTOXICITY; DNA FRAGMENTATION; GENE EXPRESSION; GENOME; GENOTYPE; IMMUNOCYTOCHEMISTRY; OVARY CANCER; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TUMOR XENOGRAFT; UVEA MELANOMA;

ATP; CANCER; CELL; CULTURE; GENOTYPING; RT-PCR;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84887084613     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.07.007     Document Type: Article

References (46)

1. S.E. Salmon, and A.W. Hamburger Immunoproliferation and cancer: a common macrophage-derived promoter substance Lancet 1 8077 Jun 17 1978 1289 1290 (PubMed PMID: 78051. Epub 1978/06/17. eng.)
2. V.N. Sumantran Cellular chemosensitivity assays: an overview Methods Mol. Biol. 731 2011 219 236 (PubMed PMID: 21516411)
3. T. Decker, and M.L. Lohmann-Matthes A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity J. Immunol. Methods 115 1 Nov 25 1988 61 69 (PubMed PMID: 3192948)
4. C. Korzeniewski, and D.M. Callewaert An enzyme-release assay for natural cytotoxicity J. Immunol. Methods 64 3 Nov 25 1983 313 320 (PubMed PMID: 6199426) (Pubitemid 14243095)
5. R.H. Batchelor, and M. Zhou Use of cellular glucose-6-phosphate dehydrogenase for cell quantitation: applications in cytotoxicity and apoptosis assays Anal. Biochem. 329 1 Jun 1 2004 35 42 (PubMed PMID: 15136165) (Pubitemid 38596899)
6. U. Scherf, D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, and L. Tanabe A gene expression database for the molecular pharmacology of cancer Nat. Genet. 24 3 Mar 2000 236 244 (PubMed PMID: 10700175) (Pubitemid 30132190)
7. K.M. Coxon, J. Duggan, M.F. Cordeiro, and S.E. Moss Purification of annexin V and its use in the detection of apoptotic cells Methods Mol. Biol. 731 2011 293 308 (PubMed PMID: 21516416)
8. J. van Meerloo, G.J. Kaspers, and J. Cloos Cell sensitivity assays: the MTT assay Methods Mol. Biol. 731 2011 237 245 (PubMed PMID: 21516412)
9. R.D. Petty, L.A. Sutherland, E.M. Hunter, and I.A. Cree Comparison of MTT and ATP-based assays for the measurement of viable cell number J. Biolumin. Chemilumin. 10 1 1995 29 34 (Jan-Feb; PubMed PMID: 7762413)
10. S. Glaysher, F.G. Gabriel, and I.A. Cree Measuring gene expression from cell cultures by quantitative reverse-transcriptase polymerase chain reaction Methods Mol. Biol. 731 2011 381 393 (PubMed PMID: 21516423)
11. P.E. Andreotti, I.A. Cree, C.M. Kurbacher, D.M. Hartmann, D. Linder, and G. Harel Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma Cancer Res. 55 22 Nov 15 1995 5276 5282 (PubMed PMID: 7585588)
12. S. Glaysher, and I.A. Cree Cell sensitivity assays: the ATP-based tumor chemosensitivity assay Methods Mol. Biol. 731 2011 247 257 (PubMed PMID: 21516413)
13. F. Di Nicolantonio, L.A. Knight, P.A. Whitehouse, S.J. Mercer, S. Sharma, and P.A. Charlton The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples Mol. Cancer Ther. 3 12 2004 Dec 1631 1637 (PubMed PMID: 15634657) (Pubitemid 40136719)
14. L.A. Knight, F. Di Nicolantonio, P. Whitehouse, S. Mercer, S. Sharma, and S. Glaysher The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours BMC Cancer 4 Nov 23 2004 83 (PubMed PMID: 15560844. PubMed Central PMCID: 535559)
15. L.A. Knight, M. Conroy, A. Fernando, M. Polak, C.M. Kurbacher, and I.A. Cree Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay Anti Cancer Drugs 16 9 Oct 2005 969 976 (PubMed PMID: 16162973) (Pubitemid 41416087)
16. L.A. Knight, F. Di Nicolantonio, P.A. Whitehouse, S.J. Mercer, S. Sharma, and S. Glaysher The effect of imatinib mesylate (Glivec) on human tumor-derived cells Anti Cancer Drugs 17 6 Jul 2006 649 655 (PubMed PMID: 16917210) (Pubitemid 44265865)
17. L.A. Knight, C.M. Kurbacher, S. Glaysher, A. Fernando, R. Reichelt, and S. Dexel Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay BMC Cancer 9 2009 38 (PubMed PMID: 19175937. PubMed Central PMCID: 2642836)
18. C.M. Kurbacher, H.W. Bruckner, I.A. Cree, J.A. Kurbacher, L. Wilhelm, and G. Poch Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial Clin. Cancer Res. 3 9 Sep 1997 1527 1533 (PubMed PMID: 9815839) (Pubitemid 27431559)
19. M.H. Neale, P.A. Charlton, and I.A. Cree Ex vivo activity of XR5000 against solid tumors Anti Cancer Drugs 11 6 Jul 2000 471 478 (PubMed PMID: 11001388)
20. J. Smith, B.J. Stewart, S. Glaysher, K. Peregrin, L.A. Knight, and D.J. Weber The effect of pentamidine on melanoma ex vivo Anti Cancer Drugs 21 2 Feb 2010 181 185 (PubMed PMID: 19966562. PubMed Central PMCID: 2866106)
21. P.A. Whitehouse, S.J. Mercer, L.A. Knight, F. Di Nicolantonio, A. O'Callaghan, and I.A. Cree Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C Br. J. Cancer 89 12 Dec 15 2003 2299 2304 (PubMed PMID: 14676810. PubMed Central PMCID: 2395279) (Pubitemid 38168015)
22. A. Fernando, S. Glaysher, M. Conroy, M. Pekalski, J. Smith, and L.A. Knight Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines Anti Cancer Drugs 17 8 Sep 2006 913 919 (PubMed PMID: 16940801) (Pubitemid 44350610)
23. I.A. Cree, S. Glaysher, and A.L. Harvey Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue Curr. Opin. Pharmacol. 10 4 Aug 2010 375 379 (PubMed PMID: 20570561)
24. P.G. Corrie, J. Shaw, V.J. Spanswick, R. Sehmbi, A. Jonson, and A. Mayer Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients Br. J. Cancer 92 11 Jun 6 2005 (1997-2003. PubMed PMID: 15886706. PubMed Central PMCID: 2361787)
25. C. Pfohler, I.A. Cree, S. Ugurel, C. Kuwert, N. Haass, and K. Neuber Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study Anti Cancer Drugs 14 5 Jun 2003 337 340 (PubMed PMID: 12782938) (Pubitemid 36683743)
26. M.H. Neale, N.E. Myatt, G.G. Khoury, P. Weaver, A. Lamont, and J.L. Hungerford Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma Melanoma Res. 11 6 Dec 2001 601 609 (PubMed PMID: 11725206) (Pubitemid 33152351)
27. P.A. Whitehouse, L.A. Knight, F. Di Nicolantonio, S.J. Mercer, S. Sharma, and I.A. Cree Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA) Anti Cancer Drugs 14 5 Jun 2003 369 375 (PubMed PMID: 12782944) (Pubitemid 36683749)
28. S.J. Mercer, S.S. Somers, L.A. Knight, P.A. Whitehouse, S. Sharma, and F. Di Nicolantonio Heterogeneity of chemosensitivity of esophageal and gastric carcinoma Anti Cancer Drugs 14 6 Jul 2003 397 403 (PubMed PMID: 12853879) (Pubitemid 36951788)
29. I.A. Cree, M.H. Neale, N.E. Myatt, P.G. de Takats, P. Hall, and J. Grant Heterogeneity of chemosensitivity of metastatic cutaneous melanoma Anti Cancer Drugs 10 5 Jun 1999 437 444 (PubMed PMID: 10477162)
30. C.M. Kurbacher, I.A. Cree, U. Brenne, H.W. Bruckner, J.A. Kurbacher, and P. Mallmann Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay Breast Cancer Res. Treat. 41 2 1996 161 170 (PubMed PMID: 8944334) (Pubitemid 26360145)
31. E.M. Hunter, L.A. Sutherland, I.A. Cree, J.A. Dewar, P.E. Preece, and R.A. Wood Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay Eur. J. Surg. Oncol. 19 3 Jun 1993 242 249 (PubMed PMID: 8314382) (Pubitemid 23215437)
32. I.A. Cree, C.M. Kurbacher, A. Lamont, A.C. Hindley, S. Love, and Group, T.C.A.O.C.T. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer Anti Cancer Drugs 18 9 Oct 2007 1093 1101 (PubMed PMID: 17704660) (Pubitemid 47294903)
33. N. Tomonaga, Y. Nakamura, H. Yamaguchi, T. Ikeda, K. Mizoguchi, and K. Motoshima Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma Clin. Lung Cancer Jun 17 2013 http://dx.doi.org/10.1016/j. cllc.2013.04.005 (Epub ahead of print)
34. S. Kim, T.M. Kim, D.W. Kim, H. Go, B. Keam, and S.H. Lee Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer J. Thorac. Oncol. 8 4 Apr 2013 415 422 (PubMed PMID: 23344087)
35. A.L. Harvey, and I.A. Cree High-throughput screening of natural products for cancer therapy Planta Med. 76 11 Aug 2010 1080 1086 (PubMed PMID: 20635309)
36. W. Yang, J. Soares, P. Greninger, E.J. Edelman, H. Lightfoot, and S. Forbes Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells Nucleic Acids Res. 41 Jan 2013 ((Database issue):D955-61. PubMed PMID: 23180760. PubMed Central PMCID: 3531057)
37. K.A. Parker, S. Glaysher, M. Polak, F.G. Gabriel, P. Johnson, and L.A. Knight The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapy J. Clin. Pathol. 63 11 Nov 2010 1012 1020 (PubMed PMID: 20924094)
38. R. Jewell, C. Conway, A. Mitra, J. Randerson-Moor, S. Lobo, and J. Nsengimana Patterns of expression of DNA repair genes and relapse from melanoma Clin. Cancer Res. 16 21 Nov 1 2010 5211 5221 (PubMed PMID: 20705614. PubMed Central PMCID: 2972254)
39. S. Glaysher, F.G. Gabriel, P. Johnson, M. Polak, L.A. Knight, and K. Parker Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy Br. J. Cancer 103 5 Aug 24 2010 656 662 (PubMed PMID: 20700122. PubMed Central PMCID: 2938260)
40. S. Glaysher, D. Yiannakis, F.G. Gabriel, P. Johnson, M.E. Polak, and L.A. Knight Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) BMC Cancer 9 2009 300 (PubMed PMID: 19712441. PubMed Central PMCID: 2739227)
41. C. Hatzis, L. Pusztai, V. Valero, D.J. Booser, L. Esserman, and A. Lluch A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer JAMA 305 18 May 11 2011 1873 1881 (PubMed PMID: 21558518)
42. J.H. van Krieken, N. Normanno, F. Blackhall, E. Boone, G. Botti, and F. Carneiro Guideline on the requirements of external quality assessment programs in molecular pathology Virchows Arch. 462 1 Jan 2013 27 37 (PubMed PMID: 23250354)
43. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 Mar 4 2011 646 674 (PubMed PMID: 21376230. Epub 2011/03/08. eng.)
44. I.A. Cree, C.M. Kurbacher, M. Untch, L.A. Sutherland, E.M. Hunter, and A.M. Subedi Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity Anti Cancer Drugs 7 6 Aug 1996 630 635 (PubMed PMID: 8913430) (Pubitemid 26348840)
45. F. Di Nicolantonio, S.J. Mercer, L.A. Knight, F.G. Gabriel, P.A. Whitehouse, and S. Sharma Cancer cell adaptation to chemotherapy BMC Cancer 5 2005 78 (PubMed PMID: 16026610. PubMed Central PMCID: 1199589)
46. T. Sasaki, J. Koivunen, A. Ogino, M. Yanagita, S. Nikiforow, and W. Zheng A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors Cancer Res. 71 18 Sep 15 2011 6051 6060 (PubMed PMID: 21791641. PubMed Central PMCID: 3278914. Epub 2011/07/28. eng.)